Literature DB >> 12127676

Serial analysis of cytokine mRNA profiles in whole blood samples from patients with early multiple sclerosis.

K G Kahl1, N Kruse, K V Toyka, P Rieckmann.   

Abstract

In this pilot study, we serially determined the cytokine messenger RNA (mRNA) expression pattern in whole blood samples from 12 patients with clinical isolated syndrome suggestive of early multiple sclerosis (MS) using a new sensitive quantitative polymerase chain reaction (PCR) method. Significantly higher levels of tumor necrosis factor-alpha (TNF-alpha; x 5.1), interferon-gamma (IFN-gamma; x 4.8) and interleukin-10 (IL-10; x 5.6) mRNA were detected in MS patients at the time of a relapse compared to healthy controls. Treatment with i.v. methylprednisolone (MP) led to an increase of IL-4 mRNA and a significant decrease of IFN-gamma and TNF-alpha mRNA expression. In this cohort of clinically stable patients, proinflammatory cytokines remained low during the 1-year follow-up period. As several indications point to a cytokine dysregulation in MS, quantitative analysis of cytokine mRNA profiles in whole blood samples by real time PCR may be a useful immunological marker to monitor disease activity in future therapeutic trials in MS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127676     DOI: 10.1016/s0022-510x(02)00136-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Immunopathology and Th1/Th2 immune response of Campylobacter jejuni-induced paralysis resembling Guillain-Barré syndrome in chicken.

Authors:  Kishan K Nyati; Kashi N Prasad; Nagendra K Kharwar; Priyanka Soni; Nuzhat Husain; Vinita Agrawal; Arun K Jain
Journal:  Med Microbiol Immunol       Date:  2011-11-19       Impact factor: 3.402

2.  Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients.

Authors:  Giovanni Frisullo; Francesco Angelucci; Massimiliano Mirabella; Marcella Caggiula; Katia Patanella; Viviana Nociti; Pietro Attilio Tonali; Anna Paola Batocchi
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

3.  Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2.

Authors:  M Zandian; K R Mott; S J Allen; O Dumitrascu; J Z Kuo; H Ghiasi
Journal:  Gene Ther       Date:  2011-03-17       Impact factor: 5.250

4.  Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis.

Authors:  Roberta Mancuso; Ambra Hernis; Simone Agostini; Marco Rovaris; Domenico Caputo; Dietmar Fuchs; Mario Clerici
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

5.  A comparative study of experimental mouse models of central nervous system demyelination.

Authors:  O M Dumitrascu; K R Mott; H Ghiasi
Journal:  Gene Ther       Date:  2014-04-10       Impact factor: 5.250

Review 6.  Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Francesco Girolamo; Cristiana Coppola; Domenico Ribatti; Maria Trojano
Journal:  Acta Neuropathol Commun       Date:  2014-07-22       Impact factor: 7.801

7.  Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.

Authors:  L Jean-Gilles; M Braitch; M L Latif; J Aram; A J Fahey; L J Edwards; R A Robins; R Tanasescu; P J Tighe; B Gran; L C Showe; S P Alexander; V Chapman; D A Kendall; C S Constantinescu
Journal:  Acta Physiol (Oxf)       Date:  2015-03-10       Impact factor: 6.311

8.  Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis.

Authors:  Federica Azzolini; Luana Gilio; Luigi Pavone; Ennio Iezzi; Ettore Dolcetti; Antonio Bruno; Fabio Buttari; Alessandra Musella; Georgia Mandolesi; Livia Guadalupi; Roberto Furlan; Annamaria Finardi; Teresa Micillo; Fortunata Carbone; Giuseppe Matarese; Diego Centonze; Mario Stampanoni Bassi
Journal:  Biomolecules       Date:  2022-01-27

Review 9.  Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repair.

Authors:  Justin R Siebert; Amanda Conta Steencken; Donna J Osterhout
Journal:  Biomed Res Int       Date:  2014-09-18       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.